Nevro to Present at the JMP Securities Life Sciences Conference

MENLO PARK, Calif., June 10, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting at the JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 in New York City. 

Nevro management is scheduled to present at 12:30 p.m. ET.  Individuals interested in listening to the presentation can access the live audio webcast on the "Investors" section of the company's website at: www.nevro.com.  An archived presentation will be available on the website for two weeks.

About Nevro

Headquartered in Menlo Park, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

Investor Relations Contact:Westwicke PartnersLynn Pieper(415) 202-5678[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nevro-to-present-at-the-jmp-securities-life-sciences-conference-300097239.html

SOURCE Nevro Corp.